<<<  EMBIT NEWSLETTER  >>>

The U.S. healthcare system continues to face mounting pressure from rising prescription drug prices, shrinking margins, and growing demand for transparency. In response to these challenges, Optum Rx has significantly expanded its cost-based pharmacy reimbursement model, transitioning all community and independent pharmacies within its network to contracts that better reflect actual drug costs.

This shift marks a meaningful departure from traditional reimbursement structures that no longer align with today’s pharmaceutical market. With full implementation targeted by January 2028, the move has important implications for community pharmacies, independent operators, healthcare providers, employers, and health plans across the United States.

For organizations navigating pharmacy reimbursement, revenue cycle management, and patient access, understanding this change is critical.

> Overview of the Cost-Based Reimbursement Expansion

Optum Rx announced that it has partnered with three additional Pharmacy Services Administrative Organizations (PSAOs), bringing more than 17,000 community & independent pharmacies under its cost-based reimbursement framework.

As a result, 100% of community and independent pharmacies participating in the Optum Rx network are now transitioning to cost-based contracts. These agreements are designed to provide more predictable reimbursement by aligning payments more closely with the actual cost pharmacies incur when purchasing medications.

Optum Rx has stated that this transition will continue through 2027, with full alignment across pharmacies, employers, and health plans expected by January 1, 2028.

> Why This Change Matters for Community Pharmacies

Rising Drug Costs Are Straining Pharmacy Operations

Prescription drug prices in the United States, particularly for brand-name and specialty medications, have increased significantly in recent years. Pharmacies purchase medications upfront and are reimbursed only after dispensing them to patients. When reimbursement fails to keep pace with acquisition costs, pharmacies absorb the financial risk.

Key trends driving this challenge include:

〉Higher launch prices for new prescription drugs in the U.S.

〉Increased reliance on specialty and biologic therapies

〉Ongoing price disparities between U.S. drug costs and those in other countries

For independent and community pharmacies operating on narrow margins, even small reimbursement gaps can threaten long-term sustainability.

> Limitations of Traditional Pharmacy Reimbursement Models

Legacy reimbursement structures were largely built during a time when generic medications dominated prescription volume. These models effectively promoted generic utilization and cost control for many years.

However, the pharmaceutical landscape has evolved:

〉Generic adoption is now widespread and mature

〉Innovation has shifted toward high-cost branded and specialty drugs

〉Benchmark pricing formulas often lag behind real-world acquisition costs

As a result, many pharmacies have struggled with unpredictable reimbursement and financial instability. Optum Rx’s cost-based model seeks to modernize this system by replacing outdated pricing logic with reimbursement that more accurately reflects actual costs.

> Key Benefits of Cost-Based Pharmacy Contracts

1. Financial Predictability

Cost-based reimbursement provides pharmacies with clearer expectations around payment, helping them manage cash flow, inventory, and operating expenses more effectively.

Predictable reimbursement reduces financial volatility and allows pharmacies to plan for growth rather than react to reimbursement shortfalls.

2. Increased Transparency

By aligning reimbursement with drug acquisition costs, the new model improves transparency across the pharmacy benefit ecosystem. Pharmacies, PBMs, employers, and health plans gain a clearer understanding of how pricing is determined and where costs originate.

This transparency helps reduce disputes, administrative burden, and uncertainty around payment methodologies.

3. Improved Patient Access

When pharmacies are reimbursed more accurately, they are better positioned to stock a broader range of medications, including high-cost brand and specialty drugs.

This is especially important in underserved and rural communities, where independent pharmacies often serve as the primary access point for prescription medications.

> Alignment With Employers & Health Plans

In addition to pharmacy network changes, Optum Rx is transitioning its employer and health plan client arrangements to align with the cost-based reimbursement approach.

By January 2028, Optum Rx aims to ensure that:

〉Client pricing reflects actual drug costs

〉Reimbursement structures are consistent across stakeholders

〉Greater transparency exists throughout the pharmacy benefit process

This alignment responds to growing demand from employers and payers for clearer insight into pharmacy spending and stronger accountability from PBMs.

> The Broader Industry Trend Toward PBM Transparency

Optum Rx’s expansion reflects a broader shift occurring across the U.S. healthcare industry.

Increased Scrutiny of PBMs

Pharmacy benefit managers face heightened scrutiny from regulators, employers, providers, and consumer advocates. Concerns around pricing opacity, rebate practices, and reimbursement fairness have accelerated calls for reform.

Cost-based reimbursement models represent one response to this pressure, aiming to create more balanced and transparent payment structures.

Rebate Pass-Through Commitments

Optum Rx has also committed to passing through 100% of negotiated drug rebates to clients by 2028. Combined with cost-based pharmacy reimbursement, this signals a significant evolution in PBM operating models focused on transparency and alignment.

> Impact on Independent and Community Pharmacies

Independent and community pharmacies stand to benefit significantly from this transition.

Operational Stability

More predictable reimbursement helps pharmacies:

〉Reduce exposure to drug price volatility

〉Maintain appropriate inventory levels

〉Stabilize cash flow and long-term planning

For many independent pharmacies, this stability is essential to remaining viable in competitive and high-cost markets.

Enhanced Role in Patient Care

When financial pressure is reduced, pharmacies can invest more in clinical and patient-facing services such as:

〉Medication counseling

〉Immunizations

〉Medication therapy management

〉Chronic disease support

This strengthens the role of community pharmacies as accessible healthcare partners.

> Implications for Healthcare Providers & Medical Practices

Although the change directly affects pharmacies, it also impacts physicians, clinics, and healthcare organizations.

Improved Medication Availability

More stable pharmacy reimbursement increases the likelihood that prescribed medications are readily available, reducing delays and substitutions that can disrupt treatment plans.

Reduced Administrative Burden

Medication access issues often create additional work for clinical and administrative staff. Improved pharmacy stability can help reduce follow-ups, re-prescribing, and patient frustration.

Support for Value-Based Care

Reliable access to medications supports adherence, continuity of care, and improved outcomes, key components of value-based healthcare models.

> Conclusion

Contact us today at info@evocarebillings.com or call (323) 412-5399 to explore how we can help your practice grow with smarter, more efficient billing solutions.